Cargando…
Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies
ABSTRACTPURPOSE: Systemic, immune, and target therapies are growing in use in the management of metastatic cancers. The aim of this review was to describe up-to-date published data on the safety and tolerability of metastasis-directed hypofractionated radiation therapy (RT) when combined with newer...
Autores principales: | Guimond, Elizabeth, Tsai, Chiaojung Jillian, Hosni, Ali, O'Kane, Grainne, Yang, Jonathan, Barry, Aisling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513086/ https://www.ncbi.nlm.nih.gov/pubmed/36177487 http://dx.doi.org/10.1016/j.adro.2022.101022 |
Ejemplares similares
-
Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions
por: Liveringhouse, Casey L., et al.
Publicado: (2021) -
Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity
por: Lewis, Shirley, et al.
Publicado: (2022) -
Metastasis-directed therapy for oligometastasis and beyond
por: Beckham, Thomas H., et al.
Publicado: (2020) -
Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020) -
The International Response to the Coronavirus Disease (2019) COVID-19 Pandemic in Radiation Oncology
por: Wang, Edina, et al.
Publicado: (2020)